Innovative Pharmaceutical Biotech (HKSE:00399) 3-Year ROIIC % : 1.08% (As of Mar. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Innovative Pharmaceutical Biotech's 3-Year ROIIC % for the quarter that ended in Mar. 2023 was 1.08%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Innovative Pharmaceutical Biotech's 3-Year ROIIC % or its related term are showing as below:

HKSE:00399's 3-Year ROIIC % is ranked worse than
51.35% of 1817 companies
in the Consumer Packaged Goods industry
Industry Median: 1.7 vs HKSE:00399: 1.08

Innovative Pharmaceutical Biotech 3-Year ROIIC % Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech 3-Year ROIIC % Chart

Innovative Pharmaceutical Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

3-Year ROIIC %

Get a 7-Day Free Trial

-1.10

2.49

0.75

-2.15

1.08

Innovative Pharmaceutical Biotech Semi-Annual Data
	Dec13	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
3-Year ROIIC %	Get a 7-Day Free Trial															-	-2.15	-	1.08	-

Competitive Comparison of Innovative Pharmaceutical Biotech's 3-Year ROIIC %

For the Household & Personal Products subindustry, Innovative Pharmaceutical Biotech's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovative Pharmaceutical Biotech's 3-Year ROIIC % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Innovative Pharmaceutical Biotech's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Innovative Pharmaceutical Biotech's 3-Year ROIIC % falls into.

Innovative Pharmaceutical Biotech 3-Year ROIIC % Calculation

Innovative Pharmaceutical Biotech's 3-Year ROIIC % for the quarter that ended in Mar. 2023 is calculated as:

3-Year ROIIC %	=	3-Year Incremental Net Operating Profit After Taxes (NOPAT)^**	/	3-Year Incremental Invested Capital^**
	=	( -20.703 (Mar. 2023) - -32.359 (Mar. 2020) )	/	( 2471.424 (Mar. 2023) - 1391.117 (Mar. 2020) )
	=	11.656	/	1080.307
	=	1.08%^***

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Innovative Pharmaceutical Biotech (HKSE:00399) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Innovative Pharmaceutical Biotech 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative Pharmaceutical Biotech (HKSE:00399) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » 3-Year ROIIC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

168-200 Connaught Road Central, Unit No. 2111, 21st Floor, Sheung Wan, West Tower Shun Tak Centre, Hong Kong, HKG

Website

http://www.ipb.asia

Innovative Pharmaceutical Biotech Ltd is focused on developing an insulin product that could be administered orally. It has two primary segments of business: the research and development of pharmaceutical products and the trading of beauty products. It generates maximum revenue from trading in the beauty products segment.

Innovative Pharmaceutical Biotech (HKSE:00399) Headlines

No Headlines